Liberty Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.51M | Hold |
6,939
| – | – | 0.19% | 76 |
|
|
2026
Q1 | $1.51M | Sell |
6,939
-286
| -4% | -$63.4K | 0.19% | 76 |
|
|
2025
Q4 | $1.65M | Sell |
7,225
-18
| -0.2% | -$4.1K | 0.21% | 69 |
|
|
2025
Q3 | $1.68M | Sell |
7,243
-47
| -0.6% | -$9.57K | 0.24% | 66 |
|
|
2025
Q2 | $1.35M | Buy |
7,290
+78
| +1% | +$14.5K | 0.21% | 69 |
|
|
2025
Q1 | $1.51M | Hold |
7,212
| – | – | 0.29% | 54 |
|
|
2024
Q4 | $1.28M | Buy |
7,212
+40
| +0.6% | +$7.35K | 0.21% | 71 |
|
|
2024
Q3 | $1.42M | Sell |
7,172
-4,469
| -38% | -$834K | 0.24% | 63 |
|
|
2024
Q2 | $1.24M | Buy |
11,641
+4,833
| +71% | +$801K | 0.23% | 66 |
|
|
2024
Q1 | $1.24M | Sell |
6,808
-362
| -5% | -$62.4K | 0.24% | 64 |
|
|
2023
Q4 | $1.11M | Buy |
7,170
+98
| +1% | +$14.3K | 0.24% | 58 |
|
|
2023
Q3 | $1.05M | Buy |
7,072
+25
| +0.4% | +$3.67K | 0.26% | 54 |
|
|
2023
Q2 | $949K | Sell |
7,047
-40
| -0.6% | -$5.87K | 0.23% | 55 |
|
|
2023
Q1 | $1.13M | Buy |
+7,087
| New | +$1.08M | 0.23% | 64 |
|
|
2022
Q3 | $943K | Sell |
7,031
-2,129
| -23% | -$306K | 0.25% | 51 |
|
|
2022
Q2 | $1.31M | Buy |
9,160
+370
| +4% | +$56.5K | 0.53% | 42 |
|
|
2022
Q1 | $1.42M | Sell |
8,790
-928
| -10% | -$135K | 0.51% | 41 |
|
|
2021
Q4 | $1.32M | Sell |
9,718
-369
| -4% | -$43.6K | 0.06% | 61 |
|
|
2021
Q3 | $1.11M | Buy |
10,087
+2,219
| +28% | +$254K | 0.4% | 41 |
|
|
2021
Q2 | $886K | Buy |
7,868
+657
| +9% | +$74K | 0.34% | 42 |
|
|
2021
Q1 | $740K | Hold |
7,211
| – | – | 0.36% | 44 |
|
|
2020
Q4 | $737K | Buy |
7,211
+1,683
| +30% | +$162K | 0.36% | 44 |
|
|
2020
Q3 | $484K | Buy |
5,528
+706
| +15% | +$66.5K | 0.29% | 55 |
|
|
2020
Q2 | $475K | Buy |
4,822
+2,424
| +101% | +$213K | 0.33% | 48 |
|
|
2020
Q1 | $183K | Buy |
2,398
+194
| +9% | +$16.5K | 0.16% | 95 |
|
|
2019
Q4 | $195K | Buy |
2,204
+796
| +57% | +$66.1K | 0.15% | 104 |
|
|
2019
Q3 | $107K | Sell |
1,408
-590
| -30% | -$40.5K | 0.1% | 139 |
|
|
2019
Q2 | $145K | Buy |
1,998
+731
| +58% | +$57.5K | 0.13% | 128 |
|
|
2019
Q1 | $102K | Sell |
1,267
-12,295
| -91% | -$1.01M | 0.08% | 135 |
|
|
2018
Q4 | $1.25M | Buy |
+13,562
| New | +$1.19M | 0.93% | 15 |
|
Other funds holding ABBV
Liberty Wealth Management's ABBV Position: Q2 2026 in Review
Liberty Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 6,939 shares worth $1.51M. The position accounts for 0.19% of the portfolio, ranked #76.
Liberty Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.68M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Liberty Wealth Management held 6,939 shares of AbbVie worth $1.51M as of Q2 2026.
- Liberty Wealth Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.19% of Liberty Wealth Management's portfolio in Q2 2026, its #76 holding.
- Liberty Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
- Liberty Wealth Management's AbbVie position peaked at $1.68M in Q3 2025.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Liberty Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.